CD4 and lung neoplasm: Alternatively, the inability to completely rule out KS and lymphoma localised in the lung, which contributed up to 50% of lung neoplasms in the pre-cART era (Parker et al, 1998), could lead to erroneous interpretations, given the strong associations of these two AIDS-defining cancers with declining CD4+ cell counts.